APrevent won 2024 MedTech Innovator Asia Pacific Grand Finals

APrevent recently achieved a significant milestone by winning the prestigious 2024 MedTech Innovator Asia Pacific Grand Finals.

2024-09-13

APrevent Medical Inc. Secures $6 Million in Series D Funding Led by Taiwania Capital

APrevent Medical Inc. is thrilled to announce the successful Series D funding round led by Taiwania Capital, a leading venture capital firm in Taiwan , backed by Taiwan’s public and private sectors which focus on investing in innovative companies in High-tech and Biotech fields.

2024-03-29

APrevent VOIS receives 2024 German NUB subsidy

APrevent VOIS, with its features of post-operative adjustment and standardized surgical procedures, effectively reduces the consumption of medical resources and provides high cost-effectiveness, has won the 2024 German New Medical Technology Additional Payment (NUB) subsidy.

2024-02-06

Partnership with Endotherapeutics Pty. Ltd. in Australia

Partnership with Endotherapeutics Pty. Ltd. in Australia

2023-11-23

VOIS TFDA Approval

VOIS TFDA Approval

2023-06-27

2023 ELS

2023 ELS

2023-06-26

Loading...